Mr. Firuta is responsibile for leading commercial strategy and operations, market access, pharmaceutical sciences & manufacturing, project management and patient advocacy. Mr. Firuta was formerly Chief Commercial Officer of from uniQure N.V. (NASDAQ: QURE) where he held the position of. Prior to uniQure, he was President of U.S. Commercial Operations at NPS Pharmaceuticals where he led the development and execution of the GATTEX sales and marketing plan as well as the commercial launch of NAPTARA. Over the course of his career, Mr. Firuta has held various leadership roles at biopharmaceutical companies including: Vice President and General Manager, Americas at ViroPharma, Inc. leading the U.S. commercial operations for CINRYZE and VANCOCIN, representing over $400 million in U.S. revenue. Additionally, he was Vice President, Managed Markets at LEV Pharmaceuticals and Executive Director National Accounts at OraPharma. Mr. Firuta holds a Master of Business Administration from St. Joseph’s University in Philadelphia and a Bachelor of Science degree from King’s College, Wilkes-Barre, Pennsylvania.